Log in
Forgot password ?
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  Danaher Corporation    DHR

Delayed Quote. Delayed  - 12/08 10:04:58 pm
77.74 USD   +1.00%
12/06 DANAHER : Announces Quarterly Dividend
12/01 DANAHER : announces leadership appointment
11/23 Global E. Coli Testing Market - Abbott Laboratories, Danaher Corp..
News SummaryMost relevantAll newsSector news 

Danaher Corporation : Danaher CEO's 2011 Compensation Rises 27% From 2010

share with twitter share with LinkedIn share with facebook
share via e-mail
03/16/2012 | 07:42pm CET

By Bob Tita


Danaher Corp. (DHR) Chief Executive H. Lawrence Culp's total compensation in 2011 rose 27% from 2010 on a larger allocation of stock and options.

Culp's base salary, nonequity bonus, compensation for executive perks and awards of restricted stock shares and options totaled $21.7 million, compared with $17.03 million in 2010, according to a regulatory filing Friday with the U.S. Securities and Exchange Commission.

The cash portion of his pay rose to 6.3% to $5.87 million because of an 8% increase, worth $350,000, in his nonequity bonus based on the performance of the diversified industrial company. His base salary was unchanged from 2010 at $1.12 million.

Danaher's profit in 2011 rose 21% to from 2010 to $2.17 billion, or $3.11 a share. Revenue climbed 28% last year to $16.1 billion. The Washington, D.C.-based company's primary business segments include testing and measurement instruments; medical and dental equipment; and industrial technologies, such as bar-code identification equipment and factory process control systems.

Culp received stock and options worth $15 million on the day they were granted, a 37% increase from the stock and options granted to him in 2010. Culp was awarded 387,080 stock options with an exercise price of $49.59. He also received restricted stock shares worth $7.68 million on the day they were granted. Culp last year exercised options for 400,000 shares of Danaher stock that netted him $11.1 million when the shares were sold at Danaher's market price. Culp also received 28,000 shares of restricted stock worth $1.54 million when the shares vested.

Danaher awarded Culp $722,068 for executive perks, contributions to his 401(k) retirement account and other expenses. Of this amount, $17,464 went to his 401(k); $396,393 covered costs for his personal use of the company's aircraft; and $56,711 went toward expenses for tax-preparation, parking and tickets to entertainment events.

Culp, 49 years old, joined Danaher 22 years ago and became chief executive in 2001. In recent years, he has realigned Danaher's business portfolio by bailing out of highly cyclical companies with large bases of fixed assets in plants, machinery and materials and investing in technology companies where growth is largely driven by research and product-development activities. In 2011, Danaher acquired medical-test maker Beckman Coulter Inc. for $5.87 billion.

Danaher's stock Friday was recently trading up 0.16% at $53.04 a share.

-By Bob Tita, Dow Jones Newswires; 312-750-4129; robert.tita@dowjones.com

share with twitter share with LinkedIn share with facebook
share via e-mail
12/06 DANAHER CORP /DE/ : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Y..
12/06 DANAHER : Announces Quarterly Dividend
12/01 DANAHER : announces leadership appointment
11/23 Global E. Coli Testing Market - Abbott Laboratories, Danaher Corporation, Bio..
11/16 DANAHER : Meritage Portfolio Management buys $7,220,284 stake in Danaher Corpora..
11/14 DANAHER : To Webcast Investor And Analyst Meeting
11/10 DANAHER CORP /DE/ : Other Events (form 8-K)
11/09 DANAHER : Van Hulzen Asset Management buys $2,893,901 stake in Danaher Corporati..
10/31 DANAHER : to Present at Baird Industrial Conference
10/27 DANAHER : Reports Third Quarter 2016 Results
More news
Sector news : Advanced Medical Equipment & Technology - NEC
12/08 AIXTRON : China's Fujian drops Aixtron bid after Obama blocks deal
12/05 Aixtron could revive takeover despite U.S. block
12/02 Deals scuppered by U.S. regulatory scrutiny
11/29 European spin-offs and carve-outs
11/15 EXCLUSIVE : EU regulators seen clearing $25 billion Abbott, St Jude deal
More sector news : Advanced Medical Equipment & Technology - NEC
News from SeekingAlpha
12/06 Danaher Corporation declares $0.125 dividend
12/04 NOVEMBER : My Fund Trumped As Interest Rates, Dollar Weigh Heavily
11/30 A Guide To Investing In Water
11/30 Fortive Could Be A New Industrial Star
11/30 Tracking Ruane, Cunniff & Goldfarb's Portfolio - Q3 2016 Update
Financials ($)
Sales 2016 16 824 M
EBIT 2016 2 959 M
Net income 2016 2 318 M
Debt 2016 7 532 M
Yield 2016 0,75%
P/E ratio 2016 23,23
P/E ratio 2017 22,74
EV / Sales 2016 3,61x
EV / Sales 2017 3,25x
Capitalization 53 240 M
More Financials
Duration : Period :
Danaher Corporation Technical Analysis Chart | DHR | US2358511028 | 4-Traders
Full-screen chart
Technical analysis trends DANAHER CORPORATION
Short TermMid-TermLong Term
Technical analysis
Income Statement Evolution
More Financials
Mean consensus OUTPERFORM
Number of Analysts 18
Average target price 89,3 $
Spread / Average Target 16%
Consensus details
EPS Revisions
More Estimates Revisions
Thomas Patrick Joyce President, Chief Executive Officer & Director
Stephen M. Rales Chairman
Daniel L. Comas Chief Financial Officer & Executive Vice President
Alan G. Spoon Independent Director
Donald Jerry Ehrlich Lead Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
PHILIPS15.41%28 279
ILLUMINA, INC.-34.15%17 925
More Results